In our complementary screen for modifiers of Aβ and tau-induced neurotoxicity, we employed a variety of additional alleles and genotypes that may better approximate the modest gene perturbations caused by AD-associated regulatory variants. The gene discussed is MAPT; the disease is Alzheimer disease.